Rockwell Medical (RMTI) Net Equity Issued and Repurchased (2010 - 2025)
Rockwell Medical's (RMTI) quarterly Net Equity Issued and Repurchased came in at $7.8 million in Q3 2025, up 114.88% YoY from $3.6 million in Q3 2024, and up 105.91% on a QoQ basis from $3.8 million in Q4 2024.
Rockwell Medical (RMTI) Net Equity Issued and Repurchased (2010 - 2025) Analysis & Trends
Rockwell Medical (RMTI) has 11 years of Net Equity Issued and Repurchased data on file, last reported at $7.8 million in Q3 2025.
- Quarterly Net Equity Issued and Repurchased rose 114.88% year-over-year to $7.8 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $7.8 million (down 23.39% YoY) and the FY2025 annual result came in at $7.8 million, down 23.23% from the prior year.
- Net Equity Issued and Repurchased advanced to $7.8 million in Q3 2025, from $3.8 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $13.8 million in Q3 2023 to a low of $560000.0 in Q1 2024.
- A 3-year average of $4.7 million and a median of $3.6 million in 2024 frame the typical range for Net Equity Issued and Repurchased.
- The widest YoY moves for Net Equity Issued and Repurchased: up 244.99% in 2024, down 73.62% in 2024.
- Tracing RMTI's Net Equity Issued and Repurchased over 3 years: stood at $1.1 million in 2023, then soared by 244.99% to $3.8 million in 2024, then jumped by 105.91% to $7.8 million in 2025.
- The last three Net Equity Issued and Repurchased figures came in at $7.8 million (Q3 2025), $3.8 million (Q4 2024), and $3.6 million (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Rockwell Medical | 29.77 Mn | 4.98 Mn | 3.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 7.80 Mn |
| Sep 30, 2025 | 7.80 Mn |
| Dec 31, 2024 | 3.79 Mn |
| Dec 31, 2024 | 3.79 Mn |
| Sep 30, 2024 | 3.63 Mn |
| Sep 30, 2024 | 3.63 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Mar 31, 2024 | 560,000.00 |
| Mar 31, 2024 | 560,000.00 |
| Dec 31, 2023 | 1.10 Mn |
| Dec 31, 2023 | 1.10 Mn |
| Sep 30, 2023 | 13.76 Mn |
| Sep 30, 2023 | 13.76 Mn |
| Sep 30, 2020 | 41.11 Mn |
| Sep 30, 2020 | 41.11 Mn |
| Jun 30, 2020 | -6.11 Mn |
| Jun 30, 2020 | -6.11 Mn |
| Mar 31, 2020 | 8.15 Mn |
| Mar 31, 2020 | 8.15 Mn |